Relationship between baseline treatment history and post-baseline relapses and serious adverse events in natalizumab-treated patients with multiple sclerosis: P890


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles